Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
06-08 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
06-08 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
03 Jun 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/amgen-takes-victory-lap-imdelltra-prolongs-life-small-cell-lung-cancer
20 May 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761024
17 May 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/amgen-hook-pay-more-400m-after-regeneron-triumphs-cholesterol-drug-antitrust-suit
07 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250507246547/en/Amgens-TEPEZZA-teprotumumab-Granted-Marketing-Authorisation-as-the-First-Targeted-Treatment-Specifically-for-Adults-With-Moderate-to-severe-Thyroid-Eye-Disease-TED-in-the-United-Kingdom
03 May 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/fda-frees-amgens-ph-1-obesity-asset-clinical-trial-hold
02 May 2025
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/amgen-quarterly-profit-tops-wall-street-view-sales-up-11-2025-05-01/
Inspections and registrations
ABOUT THIS PAGE
Chemocentryx is a supplier offers 11 products (APIs, Excipients or Intermediates).
Find a price of AMG 282 DRUG SUBSTANCE bulk with DMF offered by Chemocentryx
Find a price of AMG 191 DRUG SUBSTANCE bulk with DMF offered by Chemocentryx
Find a price of AMG 157 (TEZEPELUMAB) PHASE 3 CMC AMENDMENT (DRUG SUBSTANCE AND DRUG PRODUCT) bulk with DMF offered by Chemocentryx
Find a price of AMG 191 DRUG PRODUCT bulk with DMF offered by Chemocentryx
Find a price of INTRAVENOUS SOLUTION STABILIZER (IVSS) bulk with DMF offered by Chemocentryx
Find a price of AMG 191 CELL LINE DEVELOPMENT bulk with DMF offered by Chemocentryx
Find a price of HUMAN MONOCLONAL ANTIBODY (ABX-EGF) TO EPIDERMAL GROWTH FACTOR RECEPTOR bulk offered by Chemocentryx
Find a price of HUMAN MONOCLONAL ANTIBODY (MDX-015)(SP2/0,- AG14 CELLS, MEDAREX) TO IL15 bulk offered by Chemocentryx
Find a price of BULK PURIFIED MURINE MONOCLONAL ANTIBODY (ABX-CBL) TO BLAST CELLS bulk offered by Chemocentryx
Find a price of Carfilzomib bulk offered by Chemocentryx
Find a price of Recombinant Human Growth Hormone bulk offered by Chemocentryx